Search results
Poll: Donald Trump has sizable lead in South Dakota but shy of 2016 and 2020 numbers
Gannett via AOL· 5 hours agoTrump was at 50%, well ahead of Biden’s 31% in the poll, which was also sponsored by the Chiesman...
This Unpopular Dividend Stock Is a Buy
Motley Fool via Yahoo Finance· 1 day agoAcquisitions are slow-burn value creators in the pharmaceutical industry, frequently adding significant debt to a company's balance sheet. But they also...
Big Pharma Teva Accused of Delaying Generic Drug Competition | Connecticut Law Tribune
Law.com· 2 days agoLawsuits against large pharmaceutical companies alleging the use of inaccurate patent listings to...
Amplify Debuts New Weight Loss Drug ETF | ETF Trends
ETF Trends· 3 days agoAdditionally, the fund aims to provide investors with results similar to the performance of the VettaFi Weight Loss Drug & Treatment Index (THINR). THINR...
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP,
Guru Focus· 9 hours agoThe transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 5,500 shares of Madrigal Pharmaceuticals Inc. Madrigal Pharmaceuticals Inc is engaged in the development ...
India stocks higher at close of trade; Nifty 50 up 1.64% By Investing.com
Investing.com· 1 day agoIndia stocks higher at close of trade; Nifty 50 up 1.64%
It Looks Like Arvinas, Inc.'s (NASDAQ:ARVN) CEO May Expect Their Salary To Be Put Under The...
Simply Wall St. via Yahoo Finance· 1 day agoWhile this analysis focuses on total compensation, it's worth acknowledging that the salary portion...
Leverkusen's unbeaten season puts the spotlight on an often-overlooked German city
Newsday· 2 days agoAn often-overlooked, small German city dominated by the pharmaceuticals industry is making an...
Private Equity Is Bad for Your Health
Bloomberg· 2 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 3 days agoActavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. Forest...
